Aurentz Vincent 4
4 · Inhibikase Therapeutics, Inc. · Filed Jul 2, 2025
Insider Transaction Report
Form 4
Aurentz Vincent
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-30+108,176→ 108,176 totalExercise: $1.95Exp: 2032-06-30→ Common Stock (108,176 underlying)
Footnotes (1)
- [F1]The options will vest on the earlier of June 30, 2026 or the day prior to the next annual meeting of stockholders, subject to the director's continued service through such date.